Company / Operating Income per Share
Prime Medicine, Inc. Operating Income per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.71
FY2024
5-year range
-$6.51 / -$0.35
FY2020-FY2024
Trend
+24.2%
vs FY2023
Sector context
#104 of 196
Health Care
What the data says
At $-1.71, Prime Medicine, Inc.'s operating income per share ranks #104 of 196 in the Health Care sector. Operating Income per Share has increased for 3 consecutive years, from $-6.51 in FY2021 to $-1.71 in FY2024.
Based on SEC 10-K filings.
-1.71 in FY2024.
Improved from $-3.44 to $-1.71 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#104 of 196 in Health CareTop 53% of 196This company -$1.71 Sector average -$46.00
▼
+96.3% above sector average
Key checks
Key Insights
- Prime Medicine, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2024, operating income per share increased 24.2% year-over-year.
- Ranks #104 out of 196 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.71 | +24.2% |
| FY2023 | -$2.25 | +34.5% |
| FY2022 | -$3.44 | +47.2% |
| FY2021 | -$6.51 | -1744.2% |
| FY2020 | -$0.35 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026